This News From Novo: A Warning for Eli Lilly Shareholders
A GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
Find out which index fund best fits retirement accounts in 2024. Compare options and craft a solid retirement strategy today.
24,181 articlesA GLP-1 drug race is moving from injections to pills, reshaping the landscape for Novo Nordisk and Eli Lilly. Here’s ...
This analysis breaks down vestis (vsts) 2026 earnings for Q2, translating the transcript into actionable insights. Le...
This article breaks down Westport’s 2026 earnings landscape, translating the Q1 signals into practical moves for read...
Q1 2026 results reveal a split: Visa grows through processing scale while Mastercard expands margins with new revenue...
Investing in early-stage biotech requires a steady playbook. This article breaks down Lantern Pharma (LTRN) in 2025, ...
Oklo edges toward its first commercial nuclear power with government negotiations and a European funding alliance, ex...
Bitcoin options totaling 85,500 contracts with a $6.3 billion notional expire today, a larger-than-average end-of-mon...
A clear guide to the latest ANIP quarterly update. We unpack the numbers, translate management commentary into real-w...
Texas overtook California in the Fortune 500 rankings, flipping the script on corporate power and prompting fresh tax...
A major AI and cloud deal is flanking SpaceX's IPO, potentially nudging investor sentiment. This article breaks down ...
June’s stock market today saw Robinhood rise on the heels of an IPO underwriting announcement, signaling a potential ...
A stock down 2026 can still offer surprises. This guide breaks down bear, base, and bull scenarios for the next three...